The ASXL1 Gene Alterations in Patients with Myeloid Diseases and Chromosomal 20q Deletion

被引：0

作者：

Brezinova, Jana ^{[1
]}

Sarova, Iveta ^{[1
,2
,3
]}

Lhotska, Halka ^{[2
,3
]}

Ransdorfova, Sarka ^{[1
]}

Izakova, Silvia ^{[2
,3
]}

Svobodova, Karla ^{[2
,3
]}

Markova, Jana ^{[1
]}

Zemanova, Zuzana ^{[2
,3
]}

Cermak, Jaroslav ^{[1
]}

Jonasova, Anna T. ^{[2
]}

Michalova, Kyra ^{[1
,2
,3
]}

机构：

[1] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic

[2] Gen Univ Hosp, Prague, Czech Republic

[3] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Gelsi-Boyer, Veronique
Brecqueville, Mandy
Devillier, Raynier
Murati, Anne
Mozziconacci, Marie-Joelle
Birnbaum, Daniel
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
[22] Clinical Features of Patients with ASXL1 and ASXL2 Mutations in Pediatric Acute Myeloid Leukemia
Yamato, Genki
Shiba, Norio
Yoshida, Kenichi
Ohki, Kentaro
Park, Myoung-ja
Hara, Yusuke
Tomizawa, Daisuke
Sotomatsu, Manabu
Taga, Takashi
Adachi, Souichi
Tawa, Akio
Horibe, Keizo
Arakawa, Hirokazu
Ogawa, Seishi
Hayashi, Yasuhide
BLOOD, 2014, 124 (21)
[23] ASXL1 mutations are infrequent in young patients with primary acute myeloid leukaemia
El-Sharkawi, D.
Ali, A.
Evans, C. M.
Hills, R. K.
Burnett, A. K.
Linch, D. C.
Gale, R. E.
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 56 - 56
[24] LOCALIZATION OF THE SRC ONCOGENE TO CHROMOSOME BAND 20Q11.2 AND LOSS OF THIS GENE WITH DELETION (20Q) IN 2 LEUKEMIC PATIENTS
MORRIS, CM
HONEYBONE, LM
HOLLINGS, PE
FITZGERALD, PH
BLOOD, 1989, 74 (05) : 1768 - 1773
[25] Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion
Castillo, Martin I.
Ribate, Villamon E.
Munoz, Calabuig M.
Santillana, Sanz G.
Taboada, Such E.
Castera, Mora E.
Abinzano, Calasanz M. J.
Barranco, Irigoyen A.
Nieto, Collado R.
Pampliega, Vara M.
Blanco, M. L.
de Andres, Alvarez S.
de Oteyza, Perez J.
del Castillo, Bernal T.
Font, Granada I.
Cayuela, Jerez A.
Diez-Campelo, M.
Sanchez, Abellan R.
Vercet, Solano C.
Diaz, Tormo M.
CANCER MEDICINE, 2023, 12 (16): : 16788 - 16792
[26] Clinical implications of del(20q) in patients with hematologic myeloid disorders
Kurkova, S
Brezinova, J
Zemanova, Z
Sindelarova, L
Cermak, J
Siskova, M
Neuwirtova, R
Michalova, K
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 145 - 145
[27] FURTHER DEFINITION OF 20Q DELETION IN ACUTE MYELOID-LEUKEMIA USING MULTICOLOR FISH
RAO, PN
HAYWORTH, R
CARROLL, AJ
BOWDEN, DW
PETTENATI, MJ
CYTOGENETICS AND CELL GENETICS, 1995, 69 (1-2): : 123 - 124
[28] Myelodysplastic Syndromes (MDS) With 20q Deletion Show a High Frequency Of Associated Cytogenetic and Molecular Lesions With An Association To U2AF1, SRSF2, and Prognostically Adverse ASXL1 Mutations
Bacher, Ulrike
Haferlach, Torsten
Schnittger, Susanne
Zenger, Melanie
Meggendorfer, Manja
Roller, Andreas
Grossmann, Vera
Krauth, Maria Theresa
Jeromin, Sabine
Alpermann, Tamara
Kohlmann, Alexander
Kern, Wolfgang
Haferlach, Claudia
BLOOD, 2013, 122 (21)
[29] Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies
Okada, Michiko
Suto, Yumiko
Hirai, Momoki
Shiseki, Masayuki
Usami, Akemi
Okajima, Kaori
Teramura, Masanao
Mori, Naoki
Motoji, Toshiko
CANCER GENETICS, 2012, 205 (1-2) : 18 - 24
[30] Mental retardation in a girl with a subtelomeric deletion on chromosome 20q and complete deletion of the myelin transcription factor 1 gene (MYT1)
Kroepfl, T.
Petek, E.
Schwarzbraun, T.
Kroisel, P. M.
Plecko, B.
CLINICAL GENETICS, 2008, 73 (05) : 492 - 495

← 1 2 3 4 5 →